TriSalus Life Sciences, Inc.

General ticker "TLSI" information:

  • Sector: Health Care
  • Industry: Medical - Devices
  • Capitalization: $241.3M (TTM average)

TriSalus Life Sciences, Inc. does not follow the US Stock Market performance with the rate: -7.4%.

Estimated limits based on current volatility of 8.3%: low 2.08$, high 2.45$

Factors to consider:

  • Total employees count: 102 (-7.3%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Limited operating history, Inability to raise capital, Reimbursement failure, Market competition, Regulatory and compliance
  • Current price 46.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.09$, 10.65$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.44$, 9.21$]

Financial Metrics affecting the TLSI estimates:

  • Negative: with PPE of -3.9 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -95.84 <= 5.99
  • Positive: Inventory ratio change, % of -5.71 <= -3.92
  • Positive: Industry inventory ratio change (median), % of -0.23 <= 0
  • Positive: Interest expense per share per price, % of 2.09 <= 2.76
  • Positive: -66.29 < Industry operating profit margin (median), % of -28.79

Similar symbols

Short-term TLSI quotes

Long-term TLSI plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $18.51MM $29.43MM $45.15MM
Operating Expenses $72.99MM $65.60MM $72.10MM
Operating Income $-54.48MM $-36.16MM $-26.95MM
Non-Operating Income $-4.88MM $6.13MM $-12.27MM
Interest Expense $0.02MM $3.09MM $5.54MM
R&D Expense $29.84MM $17.69MM $14.96MM
Income(Loss) $-59.35MM $-30.04MM $-39.22MM
Taxes $0.01MM $0.01MM $0.01MM
Net Income(Loss)* $-59.36MM $-30.05MM $-39.23MM
Stockholders Equity $-27.07MM $-25.89MM $-33.86MM
Inventory $2.54MM $4.05MM $3.08MM
Assets $24.60MM $23.97MM $35.33MM
Operating Cash Flow $-50.58MM $-40.84MM $-18.01MM
Capital expenditure $0.59MM $0.34MM $0.92MM
Investing Cash Flow $-1.59MM $-0.34MM $-0.84MM
Financing Cash Flow $54.63MM $37.94MM $30.76MM
Earnings Per Share** $-2.24 $-1.13 $-1.04

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.